<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" orientation="portrait" position="float">
 <label>Table 1.
  <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml"> </span>
 </label>
 <caption>
  <title>Vaccine platforms for coronavirus.</title>
 </caption>
 <!--OASIS TABLE HERE-->
 <table frame="hsides" rules="groups">
  <colgroup>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
  </colgroup>
  <thead valign="top">
   <tr>
    <th align="left">Platform</th>
    <th align="left">Antigenic component</th>
    <th align="left">Virus</th>
    <th align="left">Notes</th>
    <th align="right">Ref.</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left">Live-attenuated vaccines</td>
    <td align="left">Whole virion</td>
    <td align="left">CoVs</td>
    <td align="left">Broad attenuation
     <break/>Low risk of reversion
    </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B46">46</xref>,
     <xref ref-type="bibr" rid="B47">47</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Inactivated vaccines</td>
    <td align="left">Whole virion</td>
    <td align="left">CoVs</td>
    <td align="left">High levels of antibodies
     <break/>Protective efficacy against SARS
    </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B49">49</xref>,
     <xref ref-type="bibr" rid="B90">90</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">DNA vaccines</td>
    <td align="left">SARS-CoV nucleocapsid protein
     <break/>SARS-CoV-2 spike protein
    </td>
    <td align="left">CoVs including SARS-CoV-2</td>
    <td align="left">Simplicity, stability and rapid production
     <break/>Safety (no infectious virus)
    </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B53">53</xref>,
     <xref ref-type="bibr" rid="B56">56</xref>,
     <xref ref-type="bibr" rid="B60">60</xref>,
     <xref ref-type="bibr" rid="B62">62</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">RNA vaccines</td>
    <td align="left">SARS-CoV-2 spike protein</td>
    <td align="left">SARS-CoV-2</td>
    <td align="left">Simplicity
     <break/>Safety (no infectious virus)
    </td>
    <td align="left">[
     <xref ref-type="bibr" rid="B64">64</xref>,
     <xref ref-type="bibr" rid="B65">65</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">Recombinant protein vaccines</td>
    <td align="left">Spike protein
     <break/>Nucleocapsid protein
     <break/>Membrane protein
    </td>
    <td align="left">CoVs including SARS-CoV-2</td>
    <td align="left">Safety (no infectious virus)
     <break/>Stimulate the immune response and release antibodies
     <break/>Adjuvants needed to increase immunogenicity
    </td>
    <td align="right">[
     <xref ref-type="bibr" rid="B80 B81 B82 B83">80â€“83</xref>,
     <xref ref-type="bibr" rid="B85">85</xref>,
     <xref ref-type="bibr" rid="B87">87</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>CoV: Coronavirus; SARS-CoV: Severe acute respiratory syndrome coronavirus.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
